Advertisement
The American Academy of Pediatrics has issued its first recommendations on tattoos

AAP Issues Clinical Report on Teen Tattoos, Piercings

0
Clinical report details possible medical complications, provides clinician guidance
A multifaceted quality improvement program improves blood pressure control over a six-month period

AHA: Multifaceted Intervention Improves BP Control

0
Increase in BP control from 65.6% to 74.8%, with significant increase in control in 12 of 16 practices
Spin in biomedical literature (also referred to as "science hype") is prevalent

‘Science Spin’ Found Prevalent in Biomedical Literature

0
Nature of spin varies, with highest variability in prevalence of spin seen in trials
Adult women have a higher prevalence of conjunctivitis than men

Conjunctivitis Prevalence Higher for Adult Women Than Men

0
Bimodal age distribution; highest rates in children younger than 7, minor mode in early adulthood
Physicians spend almost six hours per day in the electronic health record

Doctors Spend Almost Six Hours Per Day on EHR Tasks

0
Clerical and administrative tasks including order entry, billing account for almost half of hours
Most physicians on Twitter with a financial conflict of interest and frequent tweets mention specific drugs for which they have a conflict

Physicians Tweeting About Drugs May Have Conflict of Interest

0
Physicians with financial conflict of interest often mention specific drugs for which they have a conflict
Patients with fibrous dysplasia are at increased risk for breast cancer

Fibrous Dysplasia Associated With Increased Breast Cancer Risk

0
Breast cancer risk is more than three times as high in FD patients as in the general population
For many patients with type 2 diabetes

Greater Awareness Needed for Potential of T2DM Remission

0
Two test results below the diagnostic threshold, two months apart, can confirm remission
For women with diabetes

Caffeine Tied to Lower Mortality in Women With Diabetes

0
Women who consumed caffeine from coffee had reduced risk of all-cause, cardiovascular deaths
The first biosimilar drug to treat cancer has been approved by the U.S. Food and Drug Administration.

FDA Approves First Biosimilar Drug for Cancer

0
Mvasi (bevacizumab-awwb) is biosimilar to Avastin